| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/15/2004 | US6750243 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis |
| 06/15/2004 | US6750242 Positive modulators of nicotinic receptor agonists |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6750240 Methods of using bis-indolylquinones |
| 06/15/2004 | US6750239 Useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/15/2004 | US6750237 Pharmaceutical formulations containing zolmitriptan |
| 06/15/2004 | US6750235 Pramipexole as a treatment for cocaine craving |
| 06/15/2004 | US6750234 Regression of skin tumors, skin homeostases and remodeling, epidermal barrier development, hair growth, and especially wound healing. |
| 06/15/2004 | US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 06/15/2004 | US6750232 2-aminopyridine compounds and use thereof as drugs |
| 06/15/2004 | US6750231 Skin disorders; gastrointestinal disorders |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750227 Method of treatment of neuropsychiatric symptoms in patients with Alzheimer's Disease |
| 06/15/2004 | US6750226 For manufacture of medicament for use in therapy of respiratory, urinary or gastrointestinal disease |
| 06/15/2004 | US6750224 Used to systemically and topically treat bacterial gram-positive, gram-negative and anaerobic infections, especially resistant mycobacterial infections and emerging nosocomial pathogen infections |
| 06/15/2004 | US6750221 Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 06/15/2004 | US6750218 Inhibitory activity on phosphorylation of platelet-derived growth factor (pdgf) receptor useful for the treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis |
| 06/15/2004 | US6750217 Anticancer agents; cardiovascular disorders; kinase inhibitor |
| 06/15/2004 | US6750216 Kappa agonist compounds and pharmaceutical formulations thereof |
| 06/15/2004 | US6750215 Antitumor agents; anticancer agents |
| 06/15/2004 | US6750214 Quinoline and quinazoline compounds useful in therapy |
| 06/15/2004 | US6750213 Bone disorders; urogenital system disorders; anticancer agents |
| 06/15/2004 | US6750212 Photochemotherapeutic compositions |
| 06/15/2004 | US6750211 Diimino compounds for use as modulators of cell regulation |
| 06/15/2004 | US6750210 Formulation containing novel anti-inflammatory androstane derivative |
| 06/15/2004 | US6750209 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/15/2004 | US6750208 Oligosaccharides are derived from carrageenans, agars or porphyrans |
| 06/15/2004 | US6750207 Compositions for the regulation of cytokine activity |
| 06/15/2004 | US6750206 Recombinant nucleic acid vector comprising a nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 06/15/2004 | US6750205 Motilide compounds |
| 06/15/2004 | US6750196 Methods of treating disorders of the eye |
| 06/15/2004 | US6750195 Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
| 06/15/2004 | US6750058 For treatment and prevention of human and animal diseases; in particular capable of dispensing to suitable target cells nucleic sequences, proteins, peptides and chemical substances via transfection |
| 06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
| 06/15/2004 | US6750019 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 06/15/2004 | US6750012 For identifying compounds that do not induce motor side effects |
| 06/15/2004 | US6750009 Multiple viral replicon culture systems |
| 06/15/2004 | US6749870 Compositions and methods for the control of smoking |
| 06/15/2004 | US6749869 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection |
| 06/15/2004 | US6749867 Drug-containing core surrounded by inert time-release coating that delays release of drug from core until expiration of a certain time period |
| 06/15/2004 | US6749864 Stabilized pharmaceutical composition |
| 06/15/2004 | US6749854 Use of OX-2 to inhibit fetal loss |
| 06/15/2004 | US6749849 Method for producing arachidonic acid |
| 06/15/2004 | US6749845 Modulated release particles for lung delivery |
| 06/15/2004 | US6749840 Contacting the melanocyte with a melanin synthesis inhibiting amount of a fatty acid synthase (fas) inhibitor (such as cerulenin) to reduce melanin synthesis in the melanocyte |
| 06/15/2004 | US6749837 Formulations for holding and/or fixing the hair style whose mechanical performance qualities, in particular the elasticity and flexibility, are maintained irrespective of the hygrometric conditions |
| 06/15/2004 | US6749587 Modular infusion device and method |
| 06/15/2004 | US6748950 Compositions and medical procedure to treat snoring |
| 06/15/2004 | CA2313302C New metalloprotease inhibitors, the process for preparing them and the pharmaceutical compounds containing them |
| 06/15/2004 | CA2311379C Skin rash prevention composition |
| 06/15/2004 | CA2285921C Composition and method for treatment of cmv infections |
| 06/15/2004 | CA2261872C Methods of treating asthma with o-desulfated heparin |
| 06/15/2004 | CA2192714C Quasiturbine (qurbine) zero vibration - continuous combustion rotary engine, compressor and pump |
| 06/15/2004 | CA2153195C New benzopyran derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 06/15/2004 | CA2126083C Use of app modulators for the manufacture of a medicament for the treatment of amyloidosis |
| 06/15/2004 | CA2094858C Method of treating hyperproliferative vascular disease |
| 06/15/2004 | CA2086642C Method of treating hyperproliferative vascular disease |
| 06/13/2004 | CA2729967A1 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 06/13/2004 | CA2451267A1 Pharmaceutical uses for alpha2delta ligands |
| 06/10/2004 | WO2004049095A2 Betaine and salicylic acid compositions |
| 06/10/2004 | WO2004048980A1 Method for screening for compounds as potential sedatives or anxiolytics |
| 06/10/2004 | WO2004048930A2 METHOD FOR COUNTERACTING A PATHOLOGIC CHANGE IN THE ß-ADRENERGIC PATHWAY |
| 06/10/2004 | WO2004048591A2 Methods for cohort selection and longevity studies |
| 06/10/2004 | WO2004048587A1 β-1,4-MANNOBIOSE-CONTAINING COMPOSITION |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048551A2 Target for therapy of cognitive impairment |
| 06/10/2004 | WO2004048544A2 Ca ix-specific inhibitors |
| 06/10/2004 | WO2004048542A2 Mapks as modifiers of the rac, axin, and beta-catenin pathways and methods of use |
| 06/10/2004 | WO2004048524A2 Modulation of stat2 expression |
| 06/10/2004 | WO2004048504A2 Method and composition with conjugated linoleic acid esters |
| 06/10/2004 | WO2004048498A1 Antioxidant, skin preparation for external use, cosmetic and food |
| 06/10/2004 | WO2004048497A1 External composition containing highly unsaturated fatty acid or its salt or ester |
| 06/10/2004 | WO2004048496A1 Composition containing organic substance having double bond with improved oxidation stability |
| 06/10/2004 | WO2004048431A2 Polyphosphazene immunocstimulants |
| 06/10/2004 | WO2004048419A1 Method of classifying, purifying and using fenugreek seeds |
| 06/10/2004 | WO2004048405A1 Elastin substitute |
| 06/10/2004 | WO2004048382A1 Quinolinyl-pyrrolopyrazoles |
| 06/10/2004 | WO2004048379A1 Xanthine compound |
| 06/10/2004 | WO2004048378A1 Pyrazoloquinolines with immunomodulating activity |
| 06/10/2004 | WO2004048374A1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 06/10/2004 | WO2004048371A1 Indolyl derivatives |
| 06/10/2004 | WO2004048365A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 06/10/2004 | WO2004048361A1 Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
| 06/10/2004 | WO2004048358A1 Control of cancer with annonaceous extracts |
| 06/10/2004 | WO2004048356A1 Inorganic ionic molecular crystal |
| 06/10/2004 | WO2004048351A2 Biphenyl compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 06/10/2004 | WO2004048343A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/10/2004 | WO2004048339A1 Isoquinoline compounds and medicinal use thereof |
| 06/10/2004 | WO2004048338A1 Noncyclic 1,3-dicarbonyl compounds as dual ppar agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/10/2004 | WO2004048335A2 Mandelic acid derivatives |
| 06/10/2004 | WO2004048334A1 Phenyl substituted piperidine compounds for use as ppar activators |
| 06/10/2004 | WO2004048333A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/10/2004 | WO2004048330A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 06/10/2004 | WO2004048328A2 N-arylsulfonyl-3-aminoalkoxyindoles |
| 06/10/2004 | WO2004048326A1 Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
| 06/10/2004 | WO2004048322A1 Cannabinoid receptor ligands |
| 06/10/2004 | WO2004048317A1 Substituted amides active at the cannabinoid-1 receptor |
| 06/10/2004 | WO2004048314A1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 06/10/2004 | WO2004047926A1 Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone |